Selected research
Market Structure
Global Robotic IV Compounding System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Robotic IV Compounding System market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Robotic IV Compounding System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Robotic IV Compounding System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Robotic IV Compounding System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Robotic IV Compounding System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Robotic IV Compounding System include Weibond Technology, Sanggu, Lachsis, General Healthy, Shenzhen Broadcare Robots, Baxter, Steriline, Omnicell and NewIcon, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Robotic IV Compounding System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Robotic IV Compounding System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Robotic IV Compounding System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Robotic IV Compounding System market size, projected growth trends, production technologies, key applications, and end-use industries.
Robotic IV Compounding System Segment by Company
Weibond Technology
Sanggu
Lachsis
General Healthy
Shenzhen Broadcare Robots
Baxter
Steriline
Omnicell
NewIcon
Kapsam Health Products
ICU Medical
Grifols
Comecer
Arxium
Robotic IV Compounding System Segment by Type
Closed System
Non-closed System
Robotic IV Compounding System Segment by Application
Hazardous Drugs
Non-hazardous Drugs
Robotic IV Compounding System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Robotic IV Compounding System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Robotic IV Compounding System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Robotic IV Compounding System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Robotic IV Compounding System market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Robotic IV Compounding System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Robotic IV Compounding System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Robotic IV Compounding System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Closed System
- Non-closed System
Applications
- Hazardous Drugs
- Non-hazardous Drugs
Companies covered
- Weibond Technology
- Sanggu
- Lachsis
- General Healthy
- Shenzhen Broadcare Robots
- Baxter
- Steriline
- Omnicell
- NewIcon
- Kapsam Health Products
- ICU Medical
- Grifols
- Comecer
- Arxium
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Robotic IV Compounding System Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Robotic IV Compounding System Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Robotic IV Compounding System Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Robotic IV Compounding System Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Robotic IV Compounding System Market Dynamics
- 2.1 Robotic IV Compounding System Industry Trends
- 2.2 Robotic IV Compounding System Industry Drivers
- 2.3 Robotic IV Compounding System Industry Opportunities and Challenges
- 2.4 Robotic IV Compounding System Industry Restraints
3 Robotic IV Compounding System Market by Manufacturers
- 3.1 Global Robotic IV Compounding System Revenue by Manufacturers (2021-2026)
- 3.2 Global Robotic IV Compounding System Sales by Manufacturers (2021-2026)
- 3.3 Global Robotic IV Compounding System Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Robotic IV Compounding System Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Robotic IV Compounding System Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Robotic IV Compounding System Manufacturers, Product Type & Application
- 3.7 Global Robotic IV Compounding System Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Robotic IV Compounding System Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Robotic IV Compounding System Players Market Share by Revenue in 2025
- 3.8.3 2025 Robotic IV Compounding System Tier 1, Tier 2, and Tier 3
4 Robotic IV Compounding System Market by Type
- 4.1 Robotic IV Compounding System Type Introduction
- 4.1.1 Closed System
- 4.1.2 Non-closed System
- 4.2 Global Robotic IV Compounding System Sales by Type
- 4.2.1 Global Robotic IV Compounding System Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Robotic IV Compounding System Sales by Type (2021-2032)
- 4.2.3 Global Robotic IV Compounding System Sales Market Share by Type (2021-2032)
- 4.3 Global Robotic IV Compounding System Revenue by Type
- 4.3.1 Global Robotic IV Compounding System Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Robotic IV Compounding System Revenue by Type (2021-2032)
- 4.3.3 Global Robotic IV Compounding System Revenue Market Share by Type (2021-2032)
5 Robotic IV Compounding System Market by Application
- 5.1 Robotic IV Compounding System Application Introduction
- 5.1.1 Hazardous Drugs
- 5.1.2 Non-hazardous Drugs
- 5.2 Global Robotic IV Compounding System Sales by Application
- 5.2.1 Global Robotic IV Compounding System Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Robotic IV Compounding System Sales by Application (2021-2032)
- 5.2.3 Global Robotic IV Compounding System Sales Market Share by Application (2021-2032)
- 5.3 Global Robotic IV Compounding System Revenue by Application
- 5.3.1 Global Robotic IV Compounding System Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Robotic IV Compounding System Revenue by Application (2021-2032)
- 5.3.3 Global Robotic IV Compounding System Revenue Market Share by Application (2021-2032)
6 Global Robotic IV Compounding System Sales by Region
- 6.1 Global Robotic IV Compounding System Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Robotic IV Compounding System Sales by Region (2021-2032)
- 6.2.1 Global Robotic IV Compounding System Sales by Region (2021-2026)
- 6.2.2 Global Robotic IV Compounding System Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Robotic IV Compounding System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Robotic IV Compounding System Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Robotic IV Compounding System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Robotic IV Compounding System Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Robotic IV Compounding System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Robotic IV Compounding System Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Robotic IV Compounding System Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Robotic IV Compounding System Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Robotic IV Compounding System Revenue by Region
- 7.1 Global Robotic IV Compounding System Revenue by Region
- 7.1.1 Global Robotic IV Compounding System Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Robotic IV Compounding System Revenue by Region (2021-2026)
- 7.1.3 Global Robotic IV Compounding System Revenue by Region (2027-2032)
- 7.1.4 Global Robotic IV Compounding System Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Robotic IV Compounding System Revenue (2021-2032)
- 7.2.2 North America Robotic IV Compounding System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Robotic IV Compounding System Revenue (2021-2032)
- 7.3.2 Europe Robotic IV Compounding System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Robotic IV Compounding System Revenue (2021-2032)
- 7.4.2 Asia-Pacific Robotic IV Compounding System Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Robotic IV Compounding System Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Robotic IV Compounding System Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Weibond Technology
- 8.1.1 Weibond Technology Company Information
- 8.1.2 Weibond Technology Business Overview
- 8.1.3 Weibond Technology Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Weibond Technology Robotic IV Compounding System Product Portfolio
- 8.1.5 Weibond Technology Recent Developments
- 8.2 Sanggu
- 8.2.1 Sanggu Company Information
- 8.2.2 Sanggu Business Overview
- 8.2.3 Sanggu Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Sanggu Robotic IV Compounding System Product Portfolio
- 8.2.5 Sanggu Recent Developments
- 8.3 Lachsis
- 8.3.1 Lachsis Company Information
- 8.3.2 Lachsis Business Overview
- 8.3.3 Lachsis Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Lachsis Robotic IV Compounding System Product Portfolio
- 8.3.5 Lachsis Recent Developments
- 8.4 General Healthy
- 8.4.1 General Healthy Company Information
- 8.4.2 General Healthy Business Overview
- 8.4.3 General Healthy Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 General Healthy Robotic IV Compounding System Product Portfolio
- 8.4.5 General Healthy Recent Developments
- 8.5 Shenzhen Broadcare Robots
- 8.5.1 Shenzhen Broadcare Robots Company Information
- 8.5.2 Shenzhen Broadcare Robots Business Overview
- 8.5.3 Shenzhen Broadcare Robots Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Shenzhen Broadcare Robots Robotic IV Compounding System Product Portfolio
- 8.5.5 Shenzhen Broadcare Robots Recent Developments
- 8.6 Baxter
- 8.6.1 Baxter Company Information
- 8.6.2 Baxter Business Overview
- 8.6.3 Baxter Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Baxter Robotic IV Compounding System Product Portfolio
- 8.6.5 Baxter Recent Developments
- 8.7 Steriline
- 8.7.1 Steriline Company Information
- 8.7.2 Steriline Business Overview
- 8.7.3 Steriline Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Steriline Robotic IV Compounding System Product Portfolio
- 8.7.5 Steriline Recent Developments
- 8.8 Omnicell
- 8.8.1 Omnicell Company Information
- 8.8.2 Omnicell Business Overview
- 8.8.3 Omnicell Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Omnicell Robotic IV Compounding System Product Portfolio
- 8.8.5 Omnicell Recent Developments
- 8.9 NewIcon
- 8.9.1 NewIcon Company Information
- 8.9.2 NewIcon Business Overview
- 8.9.3 NewIcon Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 NewIcon Robotic IV Compounding System Product Portfolio
- 8.9.5 NewIcon Recent Developments
- 8.10 Kapsam Health Products
- 8.10.1 Kapsam Health Products Company Information
- 8.10.2 Kapsam Health Products Business Overview
- 8.10.3 Kapsam Health Products Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Kapsam Health Products Robotic IV Compounding System Product Portfolio
- 8.10.5 Kapsam Health Products Recent Developments
- 8.11 ICU Medical
- 8.11.1 ICU Medical Company Information
- 8.11.2 ICU Medical Business Overview
- 8.11.3 ICU Medical Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 ICU Medical Robotic IV Compounding System Product Portfolio
- 8.11.5 ICU Medical Recent Developments
- 8.12 Grifols
- 8.12.1 Grifols Company Information
- 8.12.2 Grifols Business Overview
- 8.12.3 Grifols Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.12.4 Grifols Robotic IV Compounding System Product Portfolio
- 8.12.5 Grifols Recent Developments
- 8.13 Comecer
- 8.13.1 Comecer Company Information
- 8.13.2 Comecer Business Overview
- 8.13.3 Comecer Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.13.4 Comecer Robotic IV Compounding System Product Portfolio
- 8.13.5 Comecer Recent Developments
- 8.14 Arxium
- 8.14.1 Arxium Company Information
- 8.14.2 Arxium Business Overview
- 8.14.3 Arxium Robotic IV Compounding System Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.14.4 Arxium Robotic IV Compounding System Product Portfolio
- 8.14.5 Arxium Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Robotic IV Compounding System Value Chain Analysis
- 9.1.1 Robotic IV Compounding System Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Robotic IV Compounding System Production Mode & Process
- 9.2 Robotic IV Compounding System Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Robotic IV Compounding System Distributors
- 9.2.3 Robotic IV Compounding System Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst